Considering the 250 ovarian carcinoma with HRDsum ≥ 42, larger proportions of 27% and 18% had BA deleterious BRCA1/2 alterations and BRCA1-hypermethylated promoters, while the proportion of tumors in the other mutation classes was lower. Here, BRCA1 is linked to ovarian carcinoma.